illumina (NASDAQ: ILMN) - 3 Technology Stocks That Build the Future-Part3

 

illumina (NASDAQ: ILMN) - 3 Technology Stocks That Build the Future-Part3

3-illumina (NASDAQ: ILMN)  After Amazon and Tesla, Illumina is one of the technology companies with long-term potential. One of the most important developments in biotechnology is the use of genetic testing.   Genetic testing used to be quite expensive. This test was used only by research organizations, governments, and universities. But the leading genetic testing platform illumina (NASDAQ: ILMN) has done a great job by lowering costs over time. illumina has become a dominant and important technology platform, with machines that analyze

illumina (NASDAQ: ILMN) 

90 %  of all genetic sequence data. The company has been able to reduce the costs of gene sequencing research by 10 thousand times since 2007. Thanks to reduced costs, genomic sequencing has gone beyond pure research environments. With Illumina's low-cost tests, it has changed the way doctors treat and screen a variety of diseases, from oncology to pre-natal testing.

In fact, a single genetic test is now required for 55 types of cancer treatments. And illumina added the $ 8 billion GRAIL, which doubled the cancer screening, to its portfolio as well, the "downside" company. Today, in the pandemic storm caused by Covid-19, vaccines were produced with the data collected from Illumina's machines. Currently, Illumina also helps track new coronavirus variants emerging around the world. It is predicted that this critical biotechnology platform will continue to gain importance in the future.

illumina (NASDAQ: ILMN) - 3 Technology Stocks That Build the Future-Part3

   

Source: The Motley Fool

 

You may also interrested in:

 

Tesla – 3 Tech Stocks That Build the Future: Part 2

Amazon.com – 3 Tech Stocks That Are Building the Future: Part 1